Clearside Biomedical, Inc.CLSDNASDAQ
Loading
Year-over-year net income growth rate
| Period | Value |
|---|---|
| Q3 2025 | -32.86% |
| Q2 2025 | 45.34% |
| Q1 2025 | -12.55% |
| Q4 2024 | 4.97% |
| Q3 2024 | -1.24% |
| Q2 2024 | 35.44% |
| Q1 2024 | -143.44% |
| Q4 2023 | 47.86% |
| Q3 2023 | -1.77% |
| Q2 2023 | 1.88% |
| Q1 2023 | 3.96% |
| Q4 2022 | -23.46% |
| Q3 2022 | -0.18% |
| Q2 2022 | -2.24% |
| Q1 2022 | -140.85% |
| Q4 2021 | 482.83% |
| Q3 2021 | 19.82% |
| Q2 2021 | 17.09% |
| Q1 2021 | -3.36% |
| Q4 2020 | -192.31% |
| Q3 2020 | 57.72% |
| Q2 2020 | -97.66% |
| Q1 2020 | 5.98% |
| Q4 2019 | 52.63% |
| Q3 2019 | -13.99% |
| Q2 2019 | 62.78% |
| Q1 2019 | 28.81% |
| Q4 2018 | 9.36% |
| Q3 2018 | -15.32% |
| Q2 2018 | -24.65% |
| Q1 2018 | -0.69% |
| Q4 2017 | 10.05% |
| Q3 2017 | -33.13% |
| Q2 2017 | -32.78% |
| Q1 2017 | -7.09% |
| Q4 2016 | -71.59% |
| Q3 2016 | -10.64% |
| Q2 2016 | 6.37% |
| Q1 2016 | -5.40% |
| Q4 2015 | -48.78% |